BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4683110)

  • 1. Hydroxyguanidines. A new class of antihypertensive agents.
    Bailey DM; DeGrazia CG
    J Med Chem; 1973 Feb; 16(2):151-6. PubMed ID: 4683110
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and antihypertensive properties of some N-(guanidinoalkyl)pyrrolidines.
    Curwain BP; Fake CS; Gordon JL; Mehta MD; Miller D; Poyser RH; Watts EA
    J Med Chem; 1971 Aug; 14(8):737-42. PubMed ID: 5114069
    [No Abstract]   [Full Text] [Related]  

  • 3. [Animal experiment and clinical studies on the action mechanism of the antihypertensive agent guancydine].
    Werning C; Vetter W; Schweikert HU; Armbruster H; Fischer N; Trübestein G; Siegenthaler W
    Verh Dtsch Ges Inn Med; 1971; 77():1004-8. PubMed ID: 5170618
    [No Abstract]   [Full Text] [Related]  

  • 4. Amidines. 4. Synthesis of tricyclic guanidines related to 1,2,3,5-tetrahydroimidazo(2,1-b)quinazoline, a new antihypertensive agent.
    Jen T; Bender P; Van Hoeven H; Dienel B; Loev B
    J Med Chem; 1973 Apr; 16(4):407-11. PubMed ID: 4716186
    [No Abstract]   [Full Text] [Related]  

  • 5. Substituted phenylacetylguanidines: a new class of antihypertensive agents.
    Bream JB; Lauener H; Picard CW; Scholtysik G; White TG
    Arzneimittelforschung; 1975 Oct; 25(10):1477-82. PubMed ID: 1243024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antihypertensive activity of 1-amino-3,4-dihydroisoquinolines.
    Diana GD; Hinshaw WB; Lape HE
    J Med Chem; 1977 Mar; 20(3):449-52. PubMed ID: 845877
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and hypotensive properties of tetrahydroisoquinolines.
    Mathison IW; Fowler KC; Morgan PH; Tidwell RR; Peters ER; Wojciechowski NJ; Lawson JW; Hetzer FK
    J Med Chem; 1973 Apr; 16(4):332-6. PubMed ID: 4716177
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
    Petersen HJ; Nielsen CK; Arrigoni-Martelli E
    J Med Chem; 1978 Aug; 21(8):773-81. PubMed ID: 691003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotensive activity of beta-heptamethylenimino-ethylaminoguanidine sulfate.
    Botton I; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1966 May; 152(2):243-50. PubMed ID: 5944368
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic results with the hypotensive agent Declinax (debrisoquin) in mild and medium forms of hypertension].
    Bückert A; Schweda E; Vich V
    Schweiz Rundsch Med Prax; 1973 Nov; 62(47):1453-60. PubMed ID: 4202234
    [No Abstract]   [Full Text] [Related]  

  • 11. Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907.
    Ryan MJ; Boucher DM; Cohen DM; Olszewski BJ; Singer RM; Smith RD; Kaplan HR
    Fed Proc; 1984 Apr; 43(5):1330-2. PubMed ID: 6323224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretic agents related to indapamide. III--Synthesis and pharmacological activity of N-(4-chloro-3-sulfamoylbenzamido)-1,2,3,4-tetrahydroquinolines and 1,2,3,4-tetrahydroisoquinolines.
    Landriani L; Barlocco D; Pinna GA; Demontis MP; Miele M; Enrico P; Anania V
    Farmaco; 1989 Nov; 44(11):1059-68. PubMed ID: 2701963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and hypotensive properties of 4-amino-6,7-dimethoxyisoquinoline.
    Wright GC; Halliday RP
    J Pharm Sci; 1974 Jan; 63(1):149-51. PubMed ID: 4811275
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and antihypertensive activity of some imidazoindole derivatives.
    Adhikary PF; Das SK; Hess BA
    J Med Chem; 1976 Nov; 19(11):1352-4. PubMed ID: 1003417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Debrisoquine, guanethidine, and bethanidine in hypertension.
    Talbot S; O'Malley BC; Bing RH
    Br Med J; 1975 May; 2(5965):278. PubMed ID: 1131592
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new drug in the medical treatment of arterial hypertension: cyclazenin].
    Mameli P; Maioli M; Fanzecu P
    Rass Int Clin Ter; 1970 Apr; 50(8):457-64. PubMed ID: 4394494
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic effects of debrisoquine sulfate in hypertension].
    Liu HW; Chen CY
    Taiwan Yi Xue Hui Za Zhi; 1972 Mar; 71(3):189-95. PubMed ID: 4506851
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and antihypertensive activity of substituted (2,6-dichlorobenzylideneamino) guanidines and some hydrazone derivatives of C-cyanoformamidrazone.
    Emilsson H; Selander H
    Acta Pharm Suec; 1988; 25(2):75-86. PubMed ID: 3218546
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical observations on the treatment of arterial hypertension with a new drug of a guanidine type: cyclazenine].
    Montagnani M; Bayelli PF; Antonelli A; Barducci O
    Clin Ter; 1968 Sep; 46(5):419-38. PubMed ID: 5747193
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of thienylcyanoguanidine derivatives as potassium channel openers.
    Yoshiizumi K; Ikeda S; Nishimura N; Yoshino K
    Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2005-10. PubMed ID: 9433770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.